CXCR4 in the tumor microenvironment may function to promote breast and prostate cancer proliferation, migration, and invasion, and our published data suggests that I3C could interrupt CXCR4/SDF-1α signaling pathway, resulting in tumor growth inhibition of breast cancer bone metastasis [101]. Here, CXCR4 is linked to breast cancer.